The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries

By Holmstrom Stefan   Buchholz Patricia   Walt John   Wickstrøm Jannie   Aagren Mark  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 897-905

Informa Healthcare

Access to resources Recommend Favorite

Comments and reply on The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries

By Soto Javier   Holmstrom Stefan   Buchholz Patricia   Walt John   Wickstrøm Jannie   Aagren Mark  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 1899-1902

Informa Healthcare

Access to resources Recommend Favorite

Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost

By Covert David   Robin Alan L.  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 971-976

Informa Healthcare

Access to resources Recommend Favorite

Comparison of morning versus evening dosing and 24-h post-dose efficacy of travoprost compared with latanoprost in patients with open-angle glaucoma**

By Yan David B.   Battista Robert A.   Haidich Anna-Bettina   Konstas Anastasios G. P.  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3023-3027

Informa Healthcare

Access to resources Recommend Favorite

A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma

By Martinez Antonio   Sanchez Manuel  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1025-1032

Informa Healthcare

Access to resources Recommend Favorite